# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5042901 | B | Displacement of [3H]-naloxone from mouse MOR expressed in CHO cells incubated for 1.5 hrs by competitive radioligand binding assay | Mus musculus | 5 | cell-based format | Scientific Literature | ||
2. | ALA5042902 | F | Agonist activity at mouse MOR expressed in CHO cell membranes assessed as stimulation of [35S]-GTPgammaS binding measured after 1 hr by scintillation counting analysis relative to DAMGO | Mus musculus | 5 | cell membrane format | Scientific Literature | ||
3. | ALA5042903 | F | Antagonist activity at mouse MOR expressed in CHO cells assessed as inhibition of DAMGO-induced calcium mobilization preincubated for 60 mins measured after 15 mins by calcium mobilization assay | Mus musculus | 5 | cell-based format | Scientific Literature | ||
4. | ALA5042905 | B | Displacement of [125I]1-alpha from recombinant rhesus macaque CCR5 expressed in Chem-1 cells incubated for 90 mins by competitive radioligand binding assay | Macaca mulatta | 4 | cell-based format | Scientific Literature | ||
5. | ALA5042907 | F | Antagonist activity at CCR5 (unknown origin) expressed in HOS cells co-expressing Gqi-5 assessed as inhibition CCL5-stimulated Ca2+ mobilization by calcium mobilization assay | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
6. | ALA5042909 | B | Inhibition of CCR5-mediated HIV-1 Bal entry in human GHOST CCR5 cells assessed as decrease in viral reverse transcriptase activity by measuring [3H]thymidine triphosphate incorporation measured after 60 to 90 mins by scintillation counting analysis | Homo sapiens | 3 | cell-based format | Scientific Literature | ||
7. | ALA5042910 | T | Cytotoxicity against human GHOST CCR5 cells assessed as reduction in cell viability measured after 6 days by XTT assay | Homo sapiens | 3 | cell-based format | Scientific Literature |